ATIENTS UNDERGOING SURGERY today are older, have more chronic medical conditions, and are taking more medications than patients a decade ago. [1] [2] [3] [4] Complications are frequent, and cardiovascular events remain the leading cause of perioperative death. 5 The annual cost of perioperative cardiovascular morbidity in the United States alone is more than $20 billion. 6 The preoperative evaluation holds the potential to reduce complications and health care costs. Yet a standard preoperative evaluation has not been defined, and routine laboratory, cardiovascular, and pulmonary tests are often performed without justification. The Joint Commission for the Accreditation of Hospitals requires all surgical patients to have a history and physical examination documented in the medical record within 30 days before surgery, but it does not define the components of the history or physical examination.
In this paper we discuss the essential elements of the preoperative evaluation, noting that many tests should not be routinely performed, but should be guided by the findings of the history and physical examination. the interview, the physician needs adequate time and interviewing skills. The history should include:
A complete review of systems to look for undiagnosed disease or inadequately controlled chronic disease. The review of systems, in conjunction with the medical history, can also identify risk factors for perioperative complications, such as alcohol or tobacco use, recent chest pain, history of deep venous thrombosis, or prior hospitalization for asthma.
An extensive medication history. This should include over-the-counter medications and herbal supplements. Recent use of anticoagulants, aspirin, and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) must be specifically sought.
Allergies, particularly allergies to rubber products and to foods associated with latex reactions, such as bananas, avocados, kiwis, apricots, and chestnuts.
Surgical and anesthetic history. Patients with a history of bleeding complications should be carefully assessed for coagulation disorders. Reactions to anesthetics by the patient or family members should raise concerns about susceptibility to malignant hyperthermia. Patients with malignant hyperthermia susceptibility require an anesthesia consultation, appropriate preparation of the operating room, and adequate equipment and expertise in the event of a malignant hyperthermic reaction.
Functional status. In addition to identified risk factors, self-reported exercise tolerance is the foundation of cardiovascular risk stratification (see discussion below) and is an independent predictor for postoperative cardiovascular complications. 12 Activity scales such as the Duke Activity Status Index 13 can help quantify the estimated metabolic equivalents generated with daily activities. For example, in formal cardiac testing, the ability to perform greater than 4 metabolic equivalents has been associated with a lower cardiovascular risk. 14 Questions about and discussion of daily activities can also help determine functional status.
The physical examination
The physical examination should build on the information gathered during the history.
For example, patients with identified chronic organ diseases such as congestive heart failure or chronic obstructive lung disease should be evaluated for uncompensated disease. Patients with a history of heavy alcohol use should be assessed for stigmata of chronic liver disease with concomitant concern for postoperative alcohol withdrawal syndromes and delirium.
A thorough preoperative evaluation optimizes outcome any hospitals now have preoperative evaluation centers through which multidisciplinary health care providers with clinical experience in perioperative care can apply a uniform and consistent preoperative evaluation to all surgical patients. These centers have demonstrated reductions in surgery cancellation rates, the use of preoperative laboratory tests and medical consultations, and improved adherence to perioperative practice guidelines. [7] [8] [9] [10] [11] The structure of the preoperative evaluation center varies from hospital to hospital, and there is no evidence that one structure is better than another, nor is their evidence to suggest a specific physician specialty should perform the preoperative evaluation.
At The Cleveland Clinic, all surgical patients are reviewed by the anesthesiology department either on the day of surgery or before. Medically complex patients are also referred to an internal medicine consultation clinic, called the IMPACT Center, before being seen by an anesthesiologist.
Communication with the surgical team is the cornerstone of perioperative medical consultation. 
M

The Preoperative Evaluation Center
Anything found in the review of systems should be addressed, particularly a new cough, fever, or symptoms of infection.
All patients should receive a thorough cardiovascular and pulmonary examination and should be asked about chronic or recent infections. Unexpected abnormal findings on the physical examination should be fully characterized and investigated before elective surgery.
s LABORATORY TESTING
Although laboratory testing is part of the preoperative evaluation, it should be recognized as optional.
Preoperative testing accounts for about $30 billion in health care costs each year. 15 The value of routine testing before elective surgery is unclear, 16 as most abnormalities in laboratory values can be predicted from the patient's history and findings of the physical examination. In addition, abnormalities discovered on laboratory testing often do not lead to changes in perioperative care. 17 Preoperative testing should therefore be viewed as selective and not routine. It cannot replace a comprehensive history and review of systems. All tests should be justified by a specific symptom, sign, or diagnosis identified during the history or physical examination.
s ASSESSING CARDIOVASCULAR RISK
Cardiac risk assessment is a critical component of the preoperative evaluation. Yet, although a great deal of research has gone into how to identify patients at risk, [18] [19] [20] [21] [22] [23] [24] little has been done to compare the various methods of risk assessment, and their overall accuracy has been questioned. 25 Many risk assessment methods use complicated algorithms and point scoring systems that can be challenging to use clinically. In addition, very little is known about strategies that may improve outcomes for patients identified at risk.
In actual practice, physicians should apply an overall risk equation defined by the patient's disease (patient risk) and the degree of surgical stress (procedural risk). How patient risk is evaluated and to what extent noninvasive cardiac stress testing is employed can be strongly affected by local factors and institutional practice.
The Lee risk index
Lee et al 26 performed a prospective cohort study to try to simplify the preoperative assessment of cardiac risk. Major cardiac complications were defined as myocardial infarction, pulmonary edema, ventricular fibrillation, primary cardiac arrest, or complete heart block. Six independent correlates of major cardiac complications were identified ( 
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The investigators found that simply assigning 1 point for each factor present and adding up the points was as accurate in predicting cardiac risk as a complicated weighting system derived by logistic regression analysis. Compared with the Goldman, Detsky, and American Society of Anesthesiology methods of preoperative risk assessment, 26 the new Lee risk index was statistically more accurate.
Noninvasive cardiac stress testing questioned
Much like the situation with laboratory testing, there is no convincing evidence that routine noninvasive cardiac stress testing improves perioperative care. 16, 27, 28 Practice guidelines recommend that noninvasive cardiac stress testing be reserved for patients with poor functional class or whose clinical risk is unclear, 22,24 despite a history, physical, and electrocardiographic evaluation. Moreover, a growing body of literature demonstrates that beta-blockers are cardioprotective when given perioperatively to patients undergoing noncardiac surgery, 5, 6, [29] [30] [31] [32] [33] further bringing into question the need for noninvasive cardiac stress testing (see below).
Boersma et al 34 retrospectively evaluated the relationships among the findings on dobutamine stress echocardiography, a modified Lee risk index (age over 70, current angina, history of myocardial infarction, cerebrovascular accident, diabetes mellitus, chronic renal failure), and beta-blocker therapy in vascular surgery patients. The main outcomes assessed were cardiac death and nonfatal myocardial infarction. Findings:
• Patients with 0 to 2 points who received beta-blockers had a low rate of cardiac complications (< 1%), irrespective of the findings on dobutamine stress echocardiography.
• Patients with a modified Lee risk index of 3 or higher who received beta-blockers also had a low rate of cardiac complications (< 1.2%)-if the dobutamine study was normal or showed fewer than four segments with new wall-motion abnormalities. However, the rate of cardiac complications was significant (> 6%) in patients with a profoundly abnormal dobutamine stress echocardiographic study, irrespective of whether they took beta-blockers.
This study suggests that patients with a Lee risk index of 0 to 2 can be given a betablocker and can proceed directly to surgery, with a low risk of complications. Patients with a score of 3 or more should be considered for further risk stratification via noninvasive cardiac stress testing but may still be at an acceptable risk level to undergo surgery while on beta-blockers if the stress test is normal. 
ACC/AHA guidelines
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perioperative cardiovascular evaluation in patients undergoing noncardiac surgery. 35 As in past guidelines, cardiac stress testing and optimization of cardiac function are recommended for patients with acute symptoms such as unstable coronary syndromes, uncompensated heart failure, or symptomatic arrhythmias. However, most patients do not have acute symptoms at the time of the preoperative evaluation.
The new ACC/AHA guidelines offer a shortcut to the decision regarding noninvasive cardiac stress testing that emphasizes the patient's functional status (TABLE 2). In general, the history and physical examination usually determine the patient's risk profile. If the risk profile is unclear, then noninvasive cardiac stress testing should be performed. Noninvasive cardiac stress testing should also be performed if the patient is thought to be at high risk, to further stratify the risk.
Most patients whose risk profile is unclear will need a pharmacologic stress test. In many instances, either stress perfusion or stress echocardiography is appropriate, as their predictive values are similar. 36 All patients with cardiovascular risk factors should receive beta-blockers perioperatively unless strongly contraindicated.
s PULMONARY RISK
Postoperative pulmonary complications such as pneumonia, atelectasis, and bronchospasm increase patient morbidity and mortality and prolong the length of hospital stay after surgery. 37, 38 Pulmonary risk factors Pulmonary risk factors have been identified (TABLE 3) , 39 but there has been no well-accepted tool to predict the risk of perioperative pulmonary complications as there is for predicting cardiac risk.
Arozullah et al 40 developed a risk-prediction tool for postoperative pneumonia in a Veterans Administration patient population. Variables included the type of surgery scheduled (abdominal aortic aneurysm repair; thoracic, upper abdominal, neck, or vascular surgery; and neurosurgery), age, functional status, weight loss, chronic obstructive pulmonary disease, general anesthesia, impaired sensorium, cerebral vascular accident, blood urea nitrogen level, transfusion, emergency surgery, long-term steroid use, smoking, and alcohol use.
Unfortunately, the clinical usefulness of this index is uncertain, since its predictor variables include specific surgical procedures not found in many presurgical referral populations.
The most important predictor of pulmonary risk is the surgical site, and that risk increases as the incision approaches the diaphragm.
The most important modifiable risk factor is smoking. Although smoking cessation leads to beneficial physiologic effects in only 48 hours, the risk for postoperative pulmonary complications declines only after 8 weeks of preoperative cessation. 41 The role for preoperative pulmonary function testing remains uncertain. No data suggest that spirometry identifies a high-risk group that would not otherwise be predicted by the history and physical examination.
Steps to reduce pulmonary risk Preoperative measures to reduce the risk of perioperative pulmonary complications include smoking cessation and aggressive treatment of active lung disease. Combinations of bronchodilators, physical therapy, antibiotics, and corticosteroids have been shown to reduce the risk of postoperative pulmonary complications in patients with chronic obstructive pulmonary disease. Asthma patients should be free of wheezing, and short courses of oral steroids do not increase the incidence of infection. 42 The mainstay of postoperative pulmonary risk reduction is lung expansion. Lung-expansion techniques include deep-breathing exercises, incentive spirometry, and continuous positive airway pressure. Preoperative education in lung-expansion maneuvers reduces pulmonary complications to a greater degree than instruction that begins after surgery. 39, 43 Preoperative pulmonary risk-reduction strategies are summarized in TABLE 4.
s MEDICATION RECOMMENDATIONS
Which medications should be continued perioperatively and which should be held? Instructions for preoperative medication use are an integral part of the preoperative evaluation, but there is little evidence to guide clinicians in this regard.
In one study, Devereaux et al 44 demonstrated that perioperative recommendations for cardiac medication use varied significantly among medical consultants. The investigators concluded that these differences may affect patient outcomes and highlight the need for randomized clinical trials to determine the impact of perioperative drug administration on surgical outcomes.
As a general principle, most prescription medications should be continued on the morning of surgery with small sips of water, unless specifically contraindicated.
Cardiovascular drugs
As mentioned above, all patients at risk for cardiovascular events should receive a selective beta-blocker. The optimum dose and length of preoperative beta-blocker therapy is not known, but metoprolol 50 mg twice daily, starting 1 week before surgery, closely mirrors research experience. 35 By convention, diuretics and angiotensinconverting enzyme (ACE) inhibitors are usually withheld the day of surgery, although we have no convincing data supporting the safety or efficacy of this practice.
Diabetic medications
Patients with diabetes should generally not take medications such as metformin or oral hypoglycemics on the day of surgery. In most cases involving diabetic patients, elective surgery is performed as a "first morning case," and patients who take insulin are advised not to take their morning insulin until they arrive at the surgery center, depending of course on the time of surgery and the patient's diabetic history. It may be appropriate to instruct patients to take half of their total insulin requirement in a long-acting insulin preparation (eg, Humulin NPH).
Herbal supplements
Recently, the American Society of Anesthesiology examined the use of herbal supplements and the potentially harmful drug interactions that may occur with continued use of these products preoperatively. 45, 46 These supplements include ginkgo biloba, St. John's wort, ginseng, saw palmetto, kava, and Echinacea. All patients are requested to discontinue their herbal supplements at least 2 weeks prior to surgery.
Drugs that potentiate bleeding
The use of medications that potentiate bleeding needs to be evaluated closely, with a riskbenefit analysis for each drug, and with a recommended time frame for discontinuation based on drug clearance and half-life charac- 
Preoperative pulmonary risk-reduction strategies
Encourage smoking cessation for at least 8 weeks preoperatively
Treat airflow obstruction in patients with chronic obstructive pulmonary disease or asthma
Give antibiotics and delay surgery if pulmonary infection is present
Begin patient education regarding lung-expansion maneuvers
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teristics. Typically, patients whose risk of bleeding exceeds their risk of thrombosis should refrain from preoperative use of aspirin for 7 to 10 days, nonselective nonsteroidal anti-inflammatory drugs for 3 to 5 days, and thienopyridines (such as clopidogrel) for a full 2 weeks before surgery. Selective cyclooxygenase-2 (COX-2) inhibitors do not potentiate bleeding and may be continued until surgery. However, caution should be exercised after surgery because of a theoretical increase in risk of cardiovascular events.
The perioperative management of patients taking warfarin is beyond the scope of this article. However, as a general rule, the patient may have surgery as long as the international normalized ratio is less than 1.5. 48 s ADDITIONAL RECOMMENDATIONS Each surgical patient should be assessed for risk for surgical site infections, bacterial endocarditis, and venous thromboembolism. Depending on the findings, recommendations should be made regarding appropriate prophylaxis against these conditions. Practice guidelines for each of these topics are reviewed elsewhere. [48] [49] [50] 
